Literature DB >> 10629078

Familial relationships in thyroid cancer by histo-pathological type.

K Hemminki1, C Dong.   

Abstract

Thyroid cancer was studied in the Swedish Family-Cancer Database, which was updated in 1999 to cover individuals born after 1934 with their biological parents, for a total of 9.6 million persons. Cancer data were obtained from the Swedish Cancer Registry from 1958 to 1996 and included 2,435 thyroid cancers among offspring. Seventy-eight families were identified in which a parent and an offspring had a thyroid cancer. The familial standardized incidence ratios (SIRs) were 7.8 and 2.5 for male and female adenocarcinomas (papillary and follicular cancer combined), giving a sex ratio of 2. 8. The familial SIRs for medullary and anaplastic carcinomas were about 4,000 and 300, respectively, without large sex difference. Medullary thyroid cancer has been coded as a separate entity since 1985, and the high familial SIR for anaplastic cancer was probably due to medullary cancer. The familial risks for all subgroups of thyroid cancer were highest in young age groups. The familial risk of medullary thyroid cancer may be the highest ever reported in population-based studies. Multiple endocrine neoplasia type 2 (MEN2) families were probably included but unambiguous diagnosis was not possible because of the coding practice. There was a strong association of medullary thyroid cancer in offspring and endocrine gland tumors in parents, which may be related to MEN2. Adenocarcinoma in offspring was not associated with discordant parental cancer. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10629078

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.

Authors:  J D McKay; D Thompson; F Lesueur; K Stankov; A Pastore; C Watfah; S Strolz; G Riccabona; R Moncayo; G Romeo; D E Goldgar
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

2.  Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation.

Authors:  Andreas Hillenbrand; Jan-Erik Varhaug; Michael Brauckhoff; Rumen Pandev; Sabine Haufe; Cornelia Dotzenrath; Roswitha Köberle; Rainer Hoffmann; Günther Klein; Martina Kadmon; Thomas Negele; Tatjana Hagieva; Doris Henne-Bruns; Markus Luster; Theresia Weber
Journal:  Langenbecks Arch Surg       Date:  2010-08-05       Impact factor: 3.445

3.  Family history of cancer and risk of sporadic differentiated thyroid carcinoma.

Authors:  Li Xu; Guojun Li; Qingyi Wei; Adel K El-Naggar; Erich M Sturgis
Journal:  Cancer       Date:  2011-07-28       Impact factor: 6.860

4.  Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.

Authors:  Willieford Moses; Julie Weng; Electron Kebebew
Journal:  Thyroid       Date:  2010-12-29       Impact factor: 6.568

Review 5.  Familial nonmedullary thyroid neoplasia.

Authors:  H Rubén Harach
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 6.  The impact of family history on non-medullary thyroid cancer.

Authors:  I J Nixon; C Suárez; R Simo; A Sanabria; P Angelos; A Rinaldo; J P Rodrigo; L P Kowalski; D M Hartl; M L Hinni; J P Shah; A Ferlito
Journal:  Eur J Surg Oncol       Date:  2016-08-11       Impact factor: 4.424

7.  Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma.

Authors:  Hugo João Prazeres; Fernando Rodrigues; Paula Soares; Plamen Naidenov; Paulo Figueiredo; Beatriz Campos; Manuela Lacerda; Teresa C Martins
Journal:  Fam Cancer       Date:  2007-09-07       Impact factor: 2.375

8.  Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implications.

Authors:  T Pal; N Hamel; D Vesprini; K Sanders; M Mitchell; N Quercia; N Ng Cheong; A Murray; W Foulkes; S A Narod
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

9.  Population-based study of familial medullary thyroid cancer.

Authors:  K Hemminki; C Dong
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

10.  Increasing incidence of thyroid cancer in Basilicata: an Italian study.

Authors:  M Capezzone; E Morabito; P Bellitti; P Giannasio; D De Sanctis; R Bruno
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.